"Inflammatory Bowel Diseases" - Books

Result Filters

See bowl (BOWEL) brother of odd with entrails limited in the Gene database

bowel in Ceratitis capitata Tribolium castaneum All 2 Gene records

Results: 1 to 20 of 824 books (4071 items)

<< First< Prev

Page of 42

Next >Last >>

Select item 44036681.

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2025 Jan-.

Top results in this book Table of Contents

Select item 44923122.

Ustekinumab (Stelara) [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Apr.

Top results in this book Table of Contents

Select item 27543143.

Colonoscopic Surveillance for Prevention of Colorectal Cancer in People with Ulcerative Colitis, Crohn's Disease or Adenomas.

London: National Institute for Health and Clinical Excellence (NICE); 2011 Mar. (NICE Clinical Guidelines, No. 118.)

Top results in this book Table of Contents

Select item 33182004.

Golimumab (Simponi) (Subcutaneous Injection): Adult Patients with Moderately to Severely Active Ulcerative Colitis Who Have Had an Inadequate Response to, or Have Medical Contraindications for, Conventional Therapies [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2014 Nov.

Top results in this book Table of Contents

Select item 43808765.

Entyvio (Vedolizumab) [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Dec.

Top results in this book Table of Contents

Select item 44929046.

Budesonide (Cortiment MMX) [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Apr.

Top results in this book Table of Contents

Select item 26591827.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].

York (UK): Centre for Reviews and Dissemination (UK); 1995-.

Top results in this book Table of Contents

Select item 31418948.

Diagnosis and Control of Johne's Disease.

National Research Council (US) Committee on Diagnosis and Control of Johne's Disease.

Washington (DC): National Academies Press (US); 2003.

Top results in this book Table of Contents

Select item 47439969.

Clinical Review Report: adalimumab (Humira) [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Apr.

Top results in this book Table of Contents

Select item 512480210.

Clinical Review Report: Vedolizumab (Entyvio SC): Takeda Canada Inc. Indication: For the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, loss of response to, or were intolerant to either conventional therapy or infliximab, a tumor necrosis factor-alpha antagonist [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Jul.

Top results in this book Table of Contents

Select item 485381611.

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].

Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.

Top results in this book Table of Contents

Select item 513915212.

Clinical Review Report: Ustekinumab (Stelara/Stelara I.V.): Janssen Inc. Indication: Treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic or have medical contraindications to such therapies [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Sep.

Top results in this book Table of Contents

Select item 467192413.

Subsequent Entry Biologic Review Report: Inflectra (infliximab) [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Nov.

Top results in this book Table of Contents

Select item 340129414.

Endotext [Internet].

Feingold KR, Ahmed SF, Anawalt B, et al., editors.

South Dartmouth (MA): MDText.com, Inc.; 2000-.

Top results in this book Table of Contents

Select item 145898415.

GeneReviews® [Internet].

Adam MP, Feldman J, Mirzaa GM, et al., editors.

Seattle (WA): University of Washington, Seattle; 1993-2025.

Top results in this book Table of Contents

Select item 532506816.

Enhancing NIH Research on Autoimmune Disease.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee for the Assessment of NIH Research on Autoimmune Diseases.

Washington (DC): National Academies Press (US); 2022 Jun 2.

Top results in this book Table of Contents

Select item 474130417.

Pharmacoeconomic Review Report: adalimumab (Humira) [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Apr.

Top results in this book Table of Contents

Select item 513758818.

Pharmacoeconomic Review Report: Ustekinumab (Stelara/Stelara I.V.): Janssen Inc. Indication: Treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic or have medical contraindications to such therapies [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Sep.

Top results in this book Table of Contents

Select item 512834819.

Pharmacoeconomic Report: Vedolizumab (Entyvio SC): Takeda Canada Inc. Indication: For the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, loss of response to, or were intolerant to either conventional therapy or infliximab, a tumor necrosis factor-alpha antagonist [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Jul.

Top results in this book Table of Contents

Select item 335043820.

Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.

Waugh N, Cummins E, Royle P, et al.

Southampton (UK): NIHR Journals Library; 2013 Nov. (Health Technology Assessment, No. 17.55.)

Top results in this book Table of Contents

<< First< Prev

Page of 42

Next >Last >>

Supplemental Content

Images search in Bookshelf

Fig. 12.2

Inflammatory bowel diseases. (a) Crohn’s disease showing complex enteroenteric fistula involving the terminal ileum (arrow), active inflammation of involved bowel loops, and strictures with small bowel dilatation. (b) NSAID enteropathy with multiple weblike strictures (arrows) and small bowel dilatation. (c) Celiac disease with decreased jejunal folds (arrow), increased ileal folds (arrowhead), and superior mesenteric vein thrombosis (dotted arrow)

Small Bowel Disease.

Hodler J, Kubik-Huch RA, von Schulthess GK, editors. Diseases of the Abdomen and Pelvis 2018-2021: Diagnostic Imaging - IDKD Book [Internet]. Cham (CH): Springer; 2018.
FIGURE 5-5The relationship among diet, the gut microbiota, and IBD

NOTE: EEN = exclusive enteral nutrition; GWAS = genome-wide association study; IBD = inflammatory bowel disease; NPO = nil per os (i.e., complete bowel rest); RD = restriction diet.
SOURCES: As presented by Gary Wu, April 3, 2018; Albenberg et al., 2012. Reprinted with permission from Wolters Kluwer: Albenberg, L. G., J. D. Lewis, and G. D. Wu. 2012. Food and the gut microbiota in inflammatory bowel diseases: A critical connection. Current Opinion in Gastroenterology 28(4):314–320. https://journals.lww.com/co-gastroenterology/pages/default.aspx (accessed June 14, 2018).

Building the Evidence Base: Research Approaches for Nutrients in Disease States.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Food and Nutrition Board. Examining Special Nutritional Requirements in Disease States: Proceedings of a Workshop. Washington (DC): National Academies Press (US); 2018 Jun 29.
Figure 1.2Example of Survey Scenario

Anti-TNF Drugs versus Long-Term Steroid Use for Patients with Inflammatory Bowel Diseases.

Lewis JD, Bewtra M, Scott FI, et al. Anti-TNF Drugs versus Long-Term Steroid Use for Patients with Inflammatory Bowel Diseases [Internet]. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2018 Nov.
Figure 1.3Participant Accruement for Phase 1

Anti-TNF Drugs versus Long-Term Steroid Use for Patients with Inflammatory Bowel Diseases.

Lewis JD, Bewtra M, Scott FI, et al. Anti-TNF Drugs versus Long-Term Steroid Use for Patients with Inflammatory Bowel Diseases [Internet]. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2018 Nov.